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Abstract: Carbon dioxide (CO2), the major product of metabolism, has a strong impact on cerebral
blood vessels, a phenomenon known as cerebrovascular reactivity. Several vascular risk factors such as
hypertension or diabetes dampen this response, making cerebrovascular reactivity a useful diagnostic
marker for incipient vascular pathology, but its functional relevance, if any, is still unclear. Here, we
found that GPR4, an endothelial H+ receptor, and endothelial G฀q/11 proteins mediate the CO2/H+ ef-
fect on cerebrovascular reactivity in mice. CO2/H+ leads to constriction of vessels in the brainstem area
that controls respiration. The consequential washout of CO2, if cerebrovascular reactivity is impaired,
reduces respiration. In contrast, CO2 dilates vessels in other brain areas such as the amygdala. Hence,
an impaired cerebrovascular reactivity amplifies the CO2 effect on anxiety. Even at atmospheric CO2
concentrations, impaired cerebrovascular reactivity caused longer apneic episodes and more anxiety, in-
dicating that cerebrovascular reactivity is essential for normal brain function. The site-specific reactivity
of vessels to CO2 is reflected by regional differences in their gene expression and the release of vasoactive
factors from endothelial cells. Our data suggest the central nervous system (CNS) endothelium as a
target to treat respiratory and affective disorders associated with vascular diseases.
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Carbon dioxide (CO2), the major product of metabolism, has a
strong impact on cerebral blood vessels, a phenomenon known
as cerebrovascular reactivity. Several vascular risk factors such as
hypertension or diabetes dampen this response, making cerebro-
vascular reactivity a useful diagnostic marker for incipient vascu-
lar pathology, but its functional relevance, if any, is still unclear.
Here, we found that GPR4, an endothelial H+ receptor, and en-
dothelial Gαq/11 proteins mediate the CO2/H
+ effect on cerebro-
vascular reactivity in mice. CO2/H
+ leads to constriction of vessels
in the brainstem area that controls respiration. The consequen-
tial washout of CO2, if cerebrovascular reactivity is impaired,
reduces respiration. In contrast, CO2 dilates vessels in other brain
areas such as the amygdala. Hence, an impaired cerebrovascular
reactivity amplifies the CO2 effect on anxiety. Even at atmo-
spheric CO2 concentrations, impaired cerebrovascular reactivity
caused longer apneic episodes and more anxiety, indicating that
cerebrovascular reactivity is essential for normal brain function.
The site-specific reactivity of vessels to CO2 is reflected by re-
gional differences in their gene expression and the release of
vasoactive factors from endothelial cells. Our data suggest the
central nervous system (CNS) endothelium as a target to treat
respiratory and affective disorders associated with vascular
diseases.
endothelial dysfunction | brain endothelial cells | hypercapnia |
respiration | anxiety
Cerebral blood flow (CBF) supplies energy substrates to thebrain and removes metabolic products. Therefore, CBF is
tightly controlled (1, 2). Since the 19th century, it has been known
that carbon dioxide (CO2)/H
+ is one of the strongest stimuli for
increasing brain perfusion (3–5). While it may seem plausible that
as the major product of metabolism CO2 increases CBF to en-
hance its removal and replenish nutrients, a physiological function
of cerebrovascular reactivity to CO2 has never been proven ex-
perimentally. Also, the molecular mechanisms underlying cere-
brovascular reactivity are still debated. This lack of knowledge is
surprising because many patients suffering from neurological,
cardiovascular, and metabolic diseases show major alterations in
cerebrovascular reactivity. In fact, cerebrovascular reactivity is
routinely monitored as a diagnostic marker to detect early stages
of vascular pathology (6). In the context of the multifaceted
conditions associated with vascular risk factors, it has been difficult
to delineate the functional consequences of impaired cerebro-
vascular reactivity. Therefore, we have investigated the mech-
anisms underlying CO2-induced perfusion changes in the brain.
Based on the obtained knowledge, we were able to selectively
interfere with cerebrovascular reactivity and unexpectedly found
that its integrity is required for the regulation of respiration and
emotional behavior.
Results
CO2-Induced CBF Response Depends Partially on GPR4. As an im-
portant mediator of the neuronal response to CO2/H
+
, ATP is
released by erythrocytes (7) and parenchymal cells (8). ATP reg-
ulates the diameter of cerebral arterioles by acting on purinergic
P2Y receptors, including P2Y2, in endothelial and smooth muscle
cells of the brain (9–11). Therefore, we examined the effect of
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deleting brain endothelial P2Y2 on CO2-induced cerebral perfu-
sion. We generated a mouse line that carries the brain endothelial-
specific cre driver Slco1c1-CreERT2 (12) combined with a loxP-
flanked P2Y2 gene (13) to delete this receptor selectively in the
brain endothelium (P2ry2beKO mice) and confirmed the knockout
by using mRNA quantification and calcium imaging in primary
forebrain endothelial cells (PFBECs) (14) (SI Appendix, Fig. S1 A
and B). To investigate the effect of CO2 on CBF, mice were
artificially ventilated with normal air or a gas mix containing in-
creased CO2 concentrations without changing oxygen levels. CBF
was measured by laser speckle imaging. CO2 induced a similar
increase in cortical perfusion of control and P2ry2beKO mice (Fig. 1
A and B). Thus, the endothelial P2Y2 receptor is not involved in
increasing cortical blood flow upon CO2 exposure. Therefore, we
tested the alternative hypothesis that CO2/H
+ could be directly
sensed by specific receptor proteins in the brain vasculature. In
buffered biological systems, CO2 is rapidly converted into protons
and bicarbonate. Protons mediate most of the physiological effects
of CO2, such as respiratory stimulation (15) or fear responses (16).
In addition, cerebral perfusion reacts to acidosis with strong va-
sodilation. Recently, several groups reported that some orphan G
protein-coupled receptors (GPCRs) were activated by H+ in a
narrow physiological range (17, 18). Among them, GPR4 and
GPR68 are expressed in vessels (18, 19). To examine the role of
H+ sensing by GPCRs during a CO2-induced CBF increase, we



































































































































































































































Fig. 1. GPR4 mediates CO2-induced perfusion increase in the cortex. (A) Representative images taken before (air) and during CO2 stimulation, and quan-
tification of laser speckle imaging measuring cortical perfusion of P2yr2beKO and control mice during artificial ventilation with 20% CO2. An exemplary region
of analysis is indicated by the white dotted box. (B) Areas under the curves shown in A; n = 19 to 20 mice per group. (C) Representative images taken before
(air) and during CO2 stimulation, and quantification of laser speckle imaging of Gpr4
−/− and control mice during artificial ventilation with 20% CO2. An
exemplary region of analysis is indicated by the white dotted box. (D) Areas under the curves shown in C. Student’s t test, **P < 0.01; n = 20 mice per group.
(E) Representative images taken before (air) and during CO2 stimulation, and quantification of laser speckle imaging of Gpr68
−/− and control mice during
artificial ventilation with 20% CO2. An exemplary region of analysis is indicated by the white dotted box. (F) Areas under the curves shown in E; n = 12 to
14 mice per group. (G) In situ hybridization of Gpr4 mRNA shows coexpression with the endothelial cell marker Pecam and colocalization with the basement
membrane protein collagen IV. (Scale bar, 10 μm.) The figure is a magnified image of SI Appendix, Fig. S1E. (H) PGF1α as a surrogate for prostacyclin release of
PFBECs of Gpr4−/− and control mice after 30-min stimulation with 5% (control) or 15% CO2. *P < 0.05 (2-way ANOVA with Bonferroni posttest); n = 12 per
group. (I) Assessment of NO release by measurement of nitrate concentrations in the supernatant of PFBECs of Gpr4−/− and control mice after 30-min
stimulation with 5% (control) or 15% CO2. *P < 0.05 (2-way ANOVA with Bonferroni posttest); n = 12 per group. Data are means ± SEM. Color scales in A, C,
and E indicate arbitrary units of laser speckle images. (Scale bars in A, C, and E, 1 mm.).











































knockout decreased CO2-induced blood flow stimulation (Fig. 1 C
and D), whereas we found no effect of the deletion of GPR68
on this response (Fig. 1 E and F). In the periphery, GPR68 is
mainly expressed in smooth muscle cells while GPR4 has been
mostly detected in endothelial cells, also in the brain (18–20).
In line with the described localization, we detected GPR68
expression in brain vessel fragments containing smooth muscle
cells, pericytes, and endothelial cells, but not in PFBECs (SI
Appendix, Fig. S1C), whereas GPR4 was enriched in both vessel
fragments and PFBECs compared to whole-brain lysate (SI
Appendix, Fig. S1D). In situ hybridization confirmed that Gpr68
mRNA is colocalized with smooth muscle cells in vessels of the
brain (SI Appendix, Fig. S1F), whereas Gpr4 mRNA is colocalized
mainly with endothelial cells in brain tissue (Fig. 1G and SI Ap-
pendix, Fig. S1E). In contrast to previous reports on another
GPR4 knockout mouse line (21), we did not observe any mor-
phological changes of the brain microvasculature (SI Appendix,
Fig. S1 G and H).
The involvement of GPR4 implies that increased CO2/H
+
concentrations are sensed by endothelial rather than by smooth
muscle cells. To characterize the endothelial signaling pathway,
we stimulated PFBECs with increased CO2 in a physiological,
bicarbonate-buffered solution, lowering the pH to ∼7.0. We mea-
sured PGF1α and nitrate as stable products of the endothelial-
derived vasodilating mediators prostacyclin and nitric oxide (NO)
and found both to be increased upon CO2 exposure (Fig. 1H and I).
Prostacyclin release but not NO release was dependent on GPR4,
indicating more than one mechanism by which CO2 induces va-
sodilation via endothelial cells. GPR4 is able to induce Gαs- and
cAMP- as well as Gαq/11-mediated signaling pathways (18, 22, 23).
Unexpectedly, CO2 did not increase, but rather decreased cAMP
production in PFBECs (SI Appendix, Fig. S2A), indicating another
mechanism in the brain endothelium, such as coupling to Gαq/11
pathways (23). Indeed, we observed a similar decrease in prostacyclin
release when we treated PFBECs with a specific and effective in-
hibitor of Gαq/11 signaling (SI Appendix, Fig. S2 B and C). Addi-
tionally, by blocking this pathway the NO release was reduced in
PFBECs after stimulation with CO2 (24) (SI Appendix, Fig. S2D).
To verify the involvement of Gαq/11 proteins, we used a
strategy that was applied successfully in previous studies (13) and
is based on the parallel deletion of Gna11 and Gnaq as the re-
spective gene products are able to compensate for each other.
We combined aGna11 knockout, loxP-flankedGnaq alleles (13),
and the brain endothelial-specific Slco1c1-CreERT2 driver (12),
leading to a tamoxifen-inducible knockout of Gαq/11 in brain en-
dothelial cells (Gαq/11
beKO mice). We confirmed the deletion by
quantifying Gnaq mRNA levels (SI Appendix, Fig. S3A) and in-
tracellular Ca2+ concentrations in PFBECs in response to ATP (SI
Appendix, Fig. S3B). As seen with the Gαq/11 inhibitor, the increase
of prostacyclin and NO release upon CO2 stimulation was clearly
reduced in PFBECs of Gαq/11
beKO mice compared to controls (SI
Appendix, Fig. S3 C and D). Supporting the involvement of NO,
the endothelial NO synthase (eNOS) was phosphorylated by CO2
and this activation was impaired in PFBECs of Gαq/11
beKO animals
(SI Appendix, Fig. S3E). Overall, the data suggest that CO2/H
+
increase cortical CBF via the endothelial H+-sensitive receptor
GPR4, intracellular Gαq/11 proteins, and the release of prostacy-
clin and NO.
CO2-Induced CBF Response Depends on Endothelial Gαq/11 Signaling.
To investigate the role of endothelial Gαq/11 signaling in the
CO2/H
+-induced cerebrovascular response in vivo, we used a gas
mix containing 10% or 20% CO2 to ventilate Gαq/11
beKO mice.
These stimuli profoundly increased arterial pCO2 and reduced
arterial pH with no difference between genotypes (SI Appendix,
Fig. S4 A–C). At a basal state, we did not find any changes in
venous blood gases inGαq/11
beKO mice (SI Appendix, Fig. S4 D–F).
The brain endothelial-specific Gαq/11 deletion interfered with
the CO2-induced CBF increase to an even greater extent than
Gpr4 knockout (Fig. 2 A–E). After a shorter stimulus of 10% CO2
there was almost no effect of CO2 on cortical perfusion in
Gαq/11
beKO mice (SI Appendix, Fig. S4 G and H). In addition,
endogenously induced CO2/H
+ elevation via hypoventilation in-
creased CBF in control mice but less so in Gαq/11
beKO animals (SI
Appendix, Fig. S4 I and J). Even short apneic periods (3 s) mark-
edly increased CBF in control mice but less so in Gαq/11
beKO
animals (Fig. 2 F–I). In contrast, the whole-genome knockout of
only Gna11 did not affect cortical CO2-induced perfusion (SI
Appendix, Fig. S4 K and L). As deleting Gαq/11 in all endothelial
cells of the body, using another cre mouse line, induced arterial
hypertension (13)—which has been shown to be a confounding fac-
tor in CBF studies—we examined the blood pressure inGαq/11
beKO
mice using telemetry. In contrast to the global endothelial de-
letion, the brain endothelial-specific deletion ofGαq/11 inGαq/11
beKO
mice did not affect blood pressure or heart rate (SI Appendix, Fig.
S4 M and N).
Laser speckle imaging is not suitable for measuring absolute
perfusion in tissues. Therefore, we used arterial spin labeling
MRI to quantify brain perfusion. We did not detect a difference
in brain perfusion between Gαq/11
beKO and control mice (Fig. 2 J
and K), which suggests that endothelial Gαq/11 signaling may not
play a role in the unstimulated cerebrovascular tone, at least
during anesthesia. However, CO2 exposure again led to a prom-
inent increase in cerebral perfusion in control mice and this effect
was diminished in Gαq/11
beKO animals (Fig. 2 J and L). The im-
paired vascular reactivity in Gαq/11
beKO mice is stimulus-specific
because the CBF response to the vasodilatory anesthetic isoflurane
did not differ betweenGαq/11
beKO and control mice, in contrast to the
response to CO2 (SI Appendix, Fig. S4O). An unchanged vessel den-
sity and normal coverage of cortical vessels by pericytes, smooth
muscle cells, and basement membrane proteins (SI Appendix, Fig.
S5 A–F) support the finding that endothelial Gαq/11 signaling is
not necessary for baseline perfusion or normal vessel morphology
in the brain, but is essential for the reactivity to CO2/H
+.
Cerebral arterioles have been reported to dilate upon CO2/H
+
(25). To investigate individual vessels, we generated acute cor-
tical brain slices and measured CO2/H
+-induced diameter changes
in arterioles by using a method described recently (26). As
expected from the above data, the deletion of endothelial Gαq/11
signaling led to a loss of CO2-induced arteriolar vessel dilation in
cortical brain slices (Fig. 2 M–O), whereas normal reactivity was
observed upon calcium withdrawal and exposure to a high con-
centration of potassium (SI Appendix, Fig. S5 G and H), demon-
strating that the reduced response to CO2/H
+ was not due to a
general morphological or functional impairment of vessel re-
activity. In support of this, diameters of unstimulated arterioles
were not altered in cortical slices of Gαq/11
beKO mice (Fig. 2P).
Taken together, our data indicate that endothelial cells play a
critical role during CO2-induced blood flow responses in the brain
as they are able to sense H+ changes by GPR4 and Gαq/11 sig-
naling and mediate the subsequent vascular reaction.
Impaired Vascular Reactivity to CO2 Aggravates CO2-Evoked Fear
Response. Having established a mouse model of impaired cere-
brovascular reactivity, we were able to investigate the physiological
functions of CO2/H
+-induced perfusion changes. Elevated CO2
concentrations elicit several behavioral and respiratory responses
that help lower CO2 in the body. As a prominent effect, CO2 leads
to what has been interpreted as a suffocation alarm (27), con-
sisting of fear and panic reactions in mice and humans by acti-
vating chemosensitive brain areas, including the basolateral amygdala
(16). To investigate cerebrovascular reactivity in the amygdala, we
prepared acute brain slices of this area and measured arteriolar
diameter changes after a CO2 stimulus. Again, as seen in cortical
slices before, elevated CO2 concentrations increased vessel diam-
eters, a response that was almost absent in slices ofGαq/11
beKO mice






















































(Fig. 3 A–C). However, no changes were seen in the effects of
control stimuli (SI Appendix, Fig. S6 A and B) or baseline di-
ameter (Fig. 3D). As CO2-induced blood flow response was im-
paired in the amygdala, we exposed freely moving mice to 10%
CO2 for 10 min to determine freezing behavior as a measure
of the fear response. Confirming its known effect, 10% CO2
increased freezing in control mice (Fig. 3 E and F) (16). Even


































































































































































































































































































































































Fig. 2. Endothelial Gαq/11 signaling mediates CO2-induced perfusion increase in the cortex. (A) Representative images of laser speckle recordings of
Gαq/11
beKO and control mice ventilated with different CO2 concentrations taken before (air) and during CO2 stimulation. Color scale indicates arbitrary units. An
exemplary region of analysis is indicated by the white dotted box. (Scale bars, 1 mm.) (B and D) Quantification of laser speckle imaging measuring cortical
perfusion of Gαq/11
beKO and control mice during artificial ventilation with 10% CO2 (B) or 20% CO2 (D). (C and E) Areas under the curves shown in B or D,
respectively. Mann–Whitney U test, *P < 0.05; n = 11 to 13 mice per group. (F and H) Quantification of laser speckle imaging measuring cortical perfusion
of Gαq/11
beKO and control mice during and after short apneic periods of 2 (F ) or 3 (H) seconds. *P < 0.05 (RM-ANOVA with Bonferroni posttest); n = 6 to
7 mice per group. (G and I) Areas under the curves shown in F or H, respectively. Mann–Whitney U test, *P < 0.05; n = 6 to 7 mice per group. (J) Representative
images of arterial spin labeling (ASL)-MRI of Gαq/11
beKO and control mice before (air) and during stimulation with 10% CO2. (K) Quantification of ASL-MRI
perfusion measurements in the cortex of unstimulated Gαq/11
beKO and control mice; n = 14 to 15 mice per group. (L) Difference in ASL-MRI perfusion mea-
surements in the cortex of CO2-exposed and unexposed Gαq/11
beKO and control mice. Student’s t test, **P < 0.01; n = 14 to 15 mice per group. (M) Repre-
sentative images of stained arterioles in acute cortical brain slices of Gαq/11
beKO and control mice before and during stimulation with CO2. (N) Representative
traces of diameter measurements in acute cortical brain slices of Gαq/11
beKO and control mice during stimulation with CO2. (O) Change in arteriolar diameters
after stimulation with CO2 in acute cortical brain slices of Gαq/11
beKO and control mice (1 arteriole per animal, mean of 3 different sites of each vessel; n = 5 to
8 mice per group). Mann–Whitney U test, *P < 0.05. (P) Baseline diameters of the measured arterioles in acute cortical brain slices of Gαq/11
beKO and control
mice; n = 5 to 8 mice per group. Data are means ± SEM.











































showed significantly more freezing behavior upon CO2 exposure
than control mice (Fig. 3 E and F). These findings point to an
important influence of vessel reactivity on the chemosensitivity
response.
During everyday activities, such as speaking in humans or
sniffing in mice, breathing is irregular, resulting in small alter-
ations in blood CO2/pH and corresponding changes in cerebral
perfusion (28). This relationship may explain why freezing be-
havior was slightly higher in Gαq/11
beKO mice already with normal
air (Fig. 3 E and F). We performed further tests to assess
baseline anxiety-like behavior. Open field test and elevated plus
maze confirmed a significantly higher anxiety-like behavior in
Gαq/11
beKO than in control mice (Fig. 3 G and H). In contrast,
coordination, grip strength, and memory, as well as explorative
and hedonic behavior did not differ between genotypes (SI Ap-
pendix, Fig. S6 C–G), indicating that cerebrovascular reactivity
is specifically required to regulate the chemosensitive fear and
anxiety-like behavior, probably because it compensates for small
fluctuations of blood CO2/pH levels. This mechanism may contrib-
ute to the increased anxiety level that is observed in obese humans
and animals in which cerebrovascular reactivity is impaired (29, 30).
Impaired Cerebrovascular Reactivity Decreases CO2-Evoked Respiration
and Prolongs Apneic Episodes. Importantly, CO2 regulates respira-
tion. CO2 increases breathing frequency and tidal volume by act-
ing on different central areas, most of which are located in the
brainstem (31). Direct sensor proteins for increased CO2/H
+, in-
cluding GPR4 and TASK2, were identified in neurons of the
retrotrapezoid nucleus (RTN) (15). Brainstem neurons that are
involved in sensing CO2 are closely associated with vessels (32,
33), placing them in an ideal position to rapidly sense CO2
changes. To examine vascular reactivity in the RTN we exposed
acute brainstem slices to CO2, measuring the arteriolar response
in the RTN. In contrast to the findings in the cortex and amyg-
dala, RTN arterioles responded to CO2 with constriction (Fig. 4
A–C), revealing opposite vascular reactivity in different brain
areas as previously reported in rats (26). Notably, RTN vessels
of Gαq/11
beKO mice did not constrict upon CO2 exposure. As
shown already for cortex and amygdala, arterioles of the RTN
responded to Ca2+ withdrawal and K+ exposure like control
vessels (SI Appendix, Fig. S7 A and B) and had the same baseline
diameter (Fig. 4D). Thus, CO2-induced cerebrovascular reac-
































































































































































































Fig. 3. Impaired vascular reactivity to CO2 in the amygdala leads to increased fear responses. (A) Representative images of stained arterioles in acute
amygdala slices of Gαq/11
beKO and control mice before and during stimulation with CO2. (B) Representative traces of diameter measurements in acute
amygdala slices of Gαq/11
beKO and control mice during stimulation with CO2. (C) Change in arteriolar diameters after stimulation with CO2 in acute amygdala
slices of Gαq/11
beKO and control mice (1 arteriole per animal, mean of 3 different sites of each vessel, n = 17 mice per group). Student’s t test, *P < 0.05. (D)
Baseline diameters of the measured arterioles in acute amygdala slices of Gαq/11
beKO and control mice; n = 17 mice per group. (E) Representative track reports
of Gαq/11
beKO and control mice exposed to normal air or CO2. (F ) Quantification of freezing behavior during a 10-min normal air or 10% CO2 exposure in
Gαq/11
beKO and control mice. *P < 0.05, ***P < 0.001 (2-way ANOVA with Bonferroni posttest); n = 16 to 17 mice per group. (G) Representative track
reports of Gαq/11
beKO and control mice during a 10-min open field test and quantification of the time mice spent in the inner zone of the open field arena.
Student’s t test, *P < 0.05; n = 13 to 16 mice per group. (H) Representative track reports ofGαq/11
beKO and control mice during a 5-min elevated plus maze test and
quantification of the time mice spent in the closed arm of the maze. Student’s t test, *P < 0.05; n = 13 to 16 mice per group. Data are means ± SEM.






















































although the effects on vessel diameters differ. To evaluate
whether the opposing reactivity of RTN and cortical arterioles is
specific for CO2 stimulation, we employed several other vasoactive
factors. Sodium nitroprusside, endothelin-1, the thromboxane
receptor agonist U46619, and ATP (SI Appendix, Fig. S7 C–F)
had similar effects on the diameter of arterioles in cortex and
brainstem slices.
To determine whether the peculiar, CO2-induced vasocon-
striction in the RTN impacts respiration, we measured breathing
parameters during CO2 exposure in awake Gαq/11
beKO and con-
trol mice. First, we used a head-out plethysmography setup and
exposed control and Gαq/11
beKO mice to different CO2 concen-
trations. In contrast to the exaggerated fear response inGαq/11
beKO
mice, changes in ventilation volume per minute upon CO2 expo-
sure were reduced and not increased in Gαq/11
beKO mice as com-
pared to control mice (Fig. 4E and SI Appendix, Fig. S8 A and B). To
verify this finding with another method, we assessed respiration by
whole-body plethysmography. The respiratory response to CO2
(10%) was again impaired in Gαq/11
beKO mice (Fig. 4F and SI
Appendix, Fig. S8 C and D). These differences were also present
under normal air conditions (SI Appendix, Fig. S8E). In sum-
mary, the data suggest that the vasoconstrictive effect of CO2 in
the RTN enhances respiratory stimulation while vasodilation in
other brain areas counteracts CO2-induced behavioral responses.
Similar to the fear behavior, we observed a tendency for dif-
fering respiration between Gαq/11
beKO and control mice during
the plethysmographic recordings already without CO2 (Fig. 4E
and SI Appendix, Fig. S8 A–E). Thus, we examined respiration
for a longer period during the inactive phase to detect apneic
episodes. We did not find any differences in the incidence of
apnea (Fig. 4G) but the duration of the apneic periods was longer
in Gαq/11
beKO than in control mice (Fig. 4 G and H), indicating a
role of blood flow in reinitiating breathing after a break in respi-
ration. In summary, the data reveal that cerebrovascular reactivity
is required to maintain normal respiration and to shorten periods
of nonbreathing. Therefore, impaired cerebrovascular reactivity would
render patients susceptible to apneic episodes, potentially explain-
ing this complication in diseases like diabetes or obesity (34, 35).
Brain Area-Dependent Vascular Gene Expression Supports Different
Regulation of CO2-Induced Vascular Reactivity. To examine the
potential basis for the opposing effects of CO2 on the vascular
reactivity in brainstem compared to other brain areas, we pre-











































































































































































































Fig. 4. Impaired vascular reactivity to CO2 leads to respiratory changes. (A) Representative images of stained arterioles in acute RTN slices of Gαq/11
beKO and
control mice before and during stimulation with CO2. (B) Representative traces of diameter measurements in acute RTN slices of Gαq/11
beKO and control mice
during stimulation with CO2. (C) Change in arteriolar diameters after stimulation with CO2 in acute RTN slices of Gαq/11
beKO and control mice (1 arteriole per
animal, mean of 3 different sites of each vessel). Student’s t test, **P < 0.01; n = 14 to 16 mice per group. (D) Baseline diameters of the measured arterioles in
acute RTN slices of Gαq/11
beKO and control mice; n = 14 to 16 mice per group. (E) Representative respiratory flow traces of Gαq/11
beKO and control mice exposed
to different concentrations of CO2 and the quantification thereof, recorded by head-out plethysmography. *P < 0.05 (RM-ANOVA with Bonferroni posttest).
(F) Respiratory flow of Gαq/11
beKO and control mice exposed to different CO2 concentrations, as recorded by whole-body plethysmography. *P < 0.05 (RM-
ANOVA with Bonferroni posttest); n = 7 to 9 mice per group. (G) Representative apnea phases of Gαq/11
beKO and control mice recorded by whole-body
plethysmography during the inactive period and quantification of the number of apneic phases; n = 9 to 10 mice per group. (H) Mean duration of all recorded
apnea within 1 h during the inactive period of the day for each mouse in Gαq/11
beKO and control mice. Student’s t test, *P < 0.05; n = 9 to 10 mice per group.
Data are means ± SEM.












































beKO mice and performed microarrays to determine mRNA
expression. The preparations from brainstem and cortex were
similar in terms of endothelial marker genes, but we found the
mRNA expression of Nos3 (eNOS) and of genes involved in
prostanoid synthesis and sensing to differ significantly between
vascular fragments of the cortex and the brainstem (SI Appen-
dix, Table S1). None of these genes differed between control and
Gαq/11
beKO mice (SI Appendix, Table S2).
To characterize the differences between brain areas further,
we prepared primary brain endothelial cells from the brainstem
and from the subcortical telencephalon (SCT) containing the
amygdala (Fig. 5A). Cultured cells were almost pure endothelial
cells (SI Appendix, Fig. S9 A and B) as described previously for
the whole forebrain (14). Interestingly, we found again some
changes in the expression of prostanoid-related genes as well as
lower expression of the Nos1 and Nos3 mRNA in brainstem
endothelial cells compared to SCT endothelial cells (SI Appendix,
Fig. S10A). When we stimulated the cells with CO2, endothelial
cells from the brainstem released less NO than the cells from the
cortex (Fig. 5B), indicating a different reactivity to CO2. Differ-
ences in the release of the prostacyclin derivative PGF1α and
PGE2 were even larger. Brainstem endothelial cells released less
of these vasodilative prostanoids in response to CO2 than SCT
endothelial cells (Fig. 5 C and D). In contrast, the CO2-induced
release of thromboxane A2, as assessed by TXB2 concentrations,
and the release of PGF2α did not differ between endothelial cells
of the SCT and the brainstem (Fig. 5 E and F). Interestingly,
vasodilation of RTN arterioles in response to the prostacyclin
analog iloprost was diminished in comparison to arterioles of the
cortex (Fig. 5G), supporting the role of prostanoids as possibly
different between brain areas. All in all, the gene expression data
as well as the different release of vasoactive compounds indicate
a highly specialized vasculature that supports the functions of
the surrounding brain region, such as breathing regulation in the
brainstem. In addition, these findings confirm that NO and pros-
tacyclin mediate CO2-induced vasodilation in the cortex.
Discussion
In this study, we demonstrate a hitherto unknown role of brain
endothelial cells in CO2-induced hyperemia and show that a loss
of this cerebrovascular reactivity affects several effects of CO2 on
the central nervous system (CNS). Interestingly, the impaired CO2
reactivity is associated with dysfunctions in fear and breathing
already with atmospheric CO2 concentrations. The response of the
brain vasculature to CO2 is thought to be mediated by changes in
pH rather than in CO2 or HCO3
− concentrations (4). In keeping
with the role of H+, GPR4, an endothelial H+-sensing GPCR,
partially mediates the CO2-induced hyperperfusion in the cortex.
GPR4 can activate Gαq/11 signaling pathways (23) and endothelial
Gαq/11 signaling, as well as GPR4, are instrumental for the CO2-
induced vascular response. These findings also suggest that en-
dothelial cells form the first line of chemosensors, which convert
metabolic blood changes rapidly into vascular diameter responses.
Endothelial cells in the brain play a crucial role in blood flow
reactivity, either by conducted hyperpolarization (36) or the re-
lease of vasoactive mediators (37). In line with reports that
endothelial-derived vasoactive NO is involved in CO2-induced
CBF increase (38, 39), we found that CO2 increased NO release in
a Gαq/11-dependent manner. The NO-dependent component of
the hypercapnia-induced hyperemia in the brain is strongest at low
concentrations of CO2 (40, 41), which fits our finding that a loss of
brain endothelial Gαq/11 signaling abrogates the CBF response at
lower CO2 concentrations but only partially reduces the response
at higher CO2 concentrations. Whether the released NO is due
to eNOS activation is unclear at this stage. Alternatively, the
neuronal NO synthase is expressed in endothelial cells and in-
volved in the CO2-induced perfusion response in the brain (42,
43). In addition to endothelial cells, pericytes, astrocytes, and





































































































































































































Fig. 5. Release of vasoactive substances differs between subcortical-telencephalic and brainstem endothelial cells. (A) Scheme of the brain areas that were
used for the preparation of area-specific primary endothelial cells. (B) Assessment of NO release by measuring nitrate concentrations in the supernatant of
SCT or brainstem endothelial cells after 20-min stimulation with 5% (control) or 15% CO2. ***P < 0.001 (2-way ANOVA with Bonferroni posttest); n = 4 to
6 per group, 2 independent experiments. (C) PGF1α as a surrogate for prostacyclin release from SCT or brainstem endothelial cells after 20-min stimulation
with 5% (control) or 15% CO2. **P < 0.01, ***P < 0.001 (2-way ANOVA with Bonferroni posttest); n = 5 to 6 per group, 2 independent experiments. (D) PGE2
release from SCT or brainstem endothelial cells after 20-min stimulation with 5% (control) or 15% CO2. ***P < 0.001 (2-way ANOVA with Bonferroni posttest);
n = 5 to 6 per group, 2 independent experiments. (E) TXB2 as a surrogate for TXA2 release from SCT or brainstem endothelial cells after 20-min stimulation
with 5% (control) or 15% CO2. P < 0.05 for treatment condition in 2-way ANOVA; n = 3 to 5 per group, 2 independent experiments. (F) PGF2α release from SCT
or brainstem endothelial cells after 20-min stimulation with 5% (control) or 15% CO2; n = 5 to 6 per group, 2 independent experiments. Absolute values of
prostanoids released by endothelial cells are shown in SI Appendix, Fig. S10B. (G) Representative traces of diameter measurements in acute cortical and RTN
brain slices of C57BL/6 mice during stimulation with 1 μM iloprost and quantification thereof (1 arteriole per animal, mean of 3 different sites of each vessel,
n = 3 mice per group). Student’s t test, *P < 0.05. Data are means ± SEM.






















































at high CO2 concentrations in Gαq/11
beKO mice (44–46). Neurons
sense pH changes and modulate cerebrovascular reactivity, me-
diated most likely by the neuronal NO synthase (46). Gαq/11 sig-
naling in brain endothelial cells not only controls the release of
vasoactive molecules, but also the activity of ion channels in
capillaries (47, 48) that are involved in the regulation of vascular
reactivity (36, 49). The activation of endothelial Gαq/11 signaling in
the brain leads to an arteriolar dilation that depends on NOS
activity (50). At the membrane, other, still unidentified endothe-
lial Gαq/11-coupled receptors might contribute to CO2-induced
cerebrovascular reactivity, but neither GPR68 nor P2Y2, both of
which are involved in endothelial shear stress responses (13, 20),
affected the CO2-induced perfusion increase.
Currently, the coupling between vessels and neurons is mostly
studied in the neuro-to-vascular direction. Conversely, the vas-
cular tone has also a direct impact on neuronal activity in the
cortex (51). In support of this idea, our data suggest that im-
paired CO2/H
+-induced cerebrovascular reactivity modulates the
behavioral and respiratory effects of CO2. Normal cerebrovas-
cular reactivity apparently attenuates the behavioral effects of
CO2, probably by facilitating its washout from most parts of the
brain (SI Appendix, Fig. S11). If cerebrovascular reactivity fails to
maintain CO2/H
+ homeostasis in the brain, CO2-induced fear is
unleashed and helps to avoid exogenous CO2 sources. In con-
trast, cerebrovascular reactivity seems to retain CO2 in the RTN,
thereby stimulating the CO2 effect on respiration and enhancing
CO2 elimination from the body. This concept is in line with the
recent finding that constriction of local vessels at the ventral
medullary surface of the brainstem increases CO2-induced
breathing activity, whereas a decreased respiratory response was
observed after local vasodilation (26). The unique features of
cerebrovascular reactivity in the RTN could be related to lower
production of vasodilatory or an increased release of vasocon-
strictive mediators upon CO2/H
+ stimulation (52). Supporting
this idea, we found highly specialized gene expression in vessels
of cortex and brainstem. Gene expression favors the synthesis of
the vasodilating NO in the cortex or SCT. To assess the endo-
thelial release of vasoactive mediators, we established the primary
culture of endothelial cells originating from different brain areas.
In these brain area-specific cell populations, CO2 induced the
release of vasodilative factors from endothelial cells of the SCT
but not the brainstem. In contrast, CO2 stimulated the release of
thromboxane similarly in both endothelial populations. It was
shown before that the synthesis of prostanoids plays a role during
hypercapnia-induced perfusion increase (53, 54) and that prosta-
noids, including the constrictive thromboxane, are released during
hypercapnia (54, 55). We conclude that upon CO2/H
+ stimulation
the release of NO and prostanoids differs in the vessels of different
parts of the brain but the initial endothelial Gαq/11-mediated
mechanism is the same. It is well described that brain areas respond
differently to a hypercapnic stimulus, including negative responses
that lead to hypoperfusion (56). In the brainstem, nuclei that are
located very close to each other have been described to respond to
CO2 in different ways (26, 56–58). Collectively, all effects seem to
serve the goal of removing CO2 from the brain, with the notable
exception of the brainstem (SI Appendix, Fig. S11). Importantly, our
findings show that specialization of vessels does not only appear
along the vascular tree in the brain (10) but also depends on the
surrounding brain area.
Impaired cerebrovascular reactivity has an impact on the be-
havioral and respiratory functions of mice already when breathing
normal air, which may be explained by small fluctuations in blood
CO2 concentration during everyday activities, such as sniffing.
Similar effects occur during speaking or sighing in humans. These
small changes are sufficient to affect both the CBF (28) and the
pH in brain extracellular fluids (59), and we have shown that short
apneic periods increase cortical perfusion in a Gαq/11-dependent
manner. Thus, short and rapid vascular responses to even small
changes in blood CO2 levels control normal brain function, at least
in CO2-sensitive areas. Impaired cerebrovascular reactivity to CO2
is a key diagnostic feature of endothelial dysfunction (39) that
develops in metabolic syndrome and in several vascular diseases
(60). Our data suggest that endothelial dysfunction in the brain
contributes to the pathogenesis of sleep apnea and anxiety disor-
ders, and maybe other diseases that are often associated with
metabolic syndrome (29, 30, 34). Thus, endothelial dysfunction in
the brain and altered cerebrovascular reactivity should be con-
sidered as a therapeutic target in several diseases, including
metabolic syndrome.
Materials and Methods
Mice. Brain endothelial-specific knockout (beKO) animals were generated by
crossing the bacterial artificial chromosome (BAC)-transgenic Slco1c1-CreERT2
strain (12), which expresses the tamoxifen-inducible CreERT2 recombinase un-
der control of the mouse Slco1c1 regulatory sequences in brain endothelial
cells, with mice carrying loxP-flanked alleles. GPR4 and GPR68 whole-genome
knockout mice have been described previously (15). All animal experiments
were approved by the local animal ethics committee (Regierungspräsidium
Karlsruhe; Ministerium für Landwirtschaft, Umwelt und ländliche Räume, Kiel,
Germany). For details see SI Appendix.
Laser Speckle Imaging. Mice were anesthetized and a small ventilatory tube
was inserted into the trachea after tracheotomy and connected to a small
animal ventilation device (MiniVent, Harvard Apparatus). Ventilation volume
was constant and ventilation frequency was adapted to a physiological ex-
piratory CO2 concentration of 35 to 45 mmHg that was continuously con-
trolled during the experiments with a capnometer. Laser speckle imaging
was performed and regions of interest were set over big cortical vessels. Flux
intensities were recorded throughout CO2 stimulation (10 or 20%, combined
with 21% O2, rest N2) and normalized to baseline values for each region of
interest. For details see SI Appendix.
Arteriolar Reactivity in Acute Brain Slices. Vascular reactivity of small arterioles
in slices of different brain areas was assessed using a protocol that was de-
scribed previously (26) with slight changes. For details see SI Appendix. Single
arterioles were identified in brain slices by typical ring-like labeling (Figs. 2M,
3A, and 4A) and a diameter of >10 μm. RTN slices were taken from the ventral
surface below the caudal end of the facial nucleus; amygdala slices were taken
1 to 1.5 mm above the ventral surface of the forebrain and the area between
the cortical and thalamic/hypothalamic structures was imaged; cortical vessels
were identified in slices taken from the somatosensory cortex.
For further method descriptions see SI Appendix.
Data Availability. Microarray data have been deposited in the ArrayExpress
database at EMBL-EBI (https://www.ebi.ac.uk/arrayexpress/) under accession
number E-MTAB-8521. All other original data files are available from the
authors upon request.
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